NABEL GARY J has a total of 18 patent applications. Its first patent ever was published in 1995. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CRUCELL SWITZERLAND AG, REDVAX GMBH and NOVAVAX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 17 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Heterocyclic compounds | |
#6 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Nabel Gary J | 18 |
#2 | Yang Zhi-Yong | 11 |
#3 | Huang Yue | 5 |
#4 | Sanchez Anthony | 4 |
#5 | Gall Jason G D | 4 |
#6 | Kong Wing-Pui | 4 |
#7 | Chakrabarti Bimal | 4 |
#8 | King C Richter | 4 |
#9 | Sullivan Nancy | 3 |
#10 | Wang Zengguang | 3 |
Publication | Filing date | Title |
---|---|---|
US2014170186A1 | Virus-like particles and methods of use | |
US2012219583A1 | Nucleic acid sequences encoding expandable hiv mosaic proteins | |
US2012219584A1 | Protection against pandemic and seasonal strains of influenza |